#  Award Recipients 

 



  Open all sections   Close all sections  



###    2025 BIECIA Award Recipients  expand\_more  

**Elucidating the interplay of Warburg metabolism, membrane potential, and signaling in cancer**  
[Markus Basan](https://basan.med.harvard.edu/), PhD (Harvard Medical School)

**Elucidating the role of ciliary transport in polycystic kidney disease pathogenesis**  
[Alan Brown](https://brown.hms.harvard.edu/), PhD (Harvard Medical School)

**Discovery and manipulation of gut bacterial chemistry for the betterment of human health**  
[Sloan Devlin](https://devlin.hms.harvard.edu/), PhD (Harvard Medical School)

**The rulebook of molecular recognition: Lessons from chemosensory receptors**  
[Josefina del Mármol](https://delmarmol.hms.harvard.edu/), PhD (Harvard Medical School)

**Mechanisms of transcription, replication, and DNA repair**  
[Lucas Farnung](https://www.farnunglab.com/), PhD (Harvard Medical School)

**Immunological control of lung homeostasis and repair**  
[Ruth Franklin](https://www.ruthfranklinlab.com/), PhD (Harvard Medical School)

**Messengers of mayhem: Unveiling the impact of chimeric mRNA in inflammatory and neurodegenerative disease**  
[Ruaidhri Jackson](https://www.jacksonimmunology.com/), PhD (Harvard Medical School)

**Dissecting circuit motifs of innate and adaptive behaviors**  
[Wei-Chung Lee](https://www.lee.hms.harvard.edu/), PhD (Harvard Medical School)

**Dissecting specialized secretory biosynthetic mechanisms**  
[Susan Shao](https://shao.hms.harvard.edu/), PhD (Harvard Medical School)

**Chemical rescue of somatic mutations in cancer**  
[Qinheng Zheng](https://sites.harvard.edu/zheng/), PhD (Harvard Medical School)

 

 [  arrow\_forward  Read about the 2025 BIECIA projects ](https://hms.harvard.edu/news/hms-announces-blavatnik-institute-early-career-investigator-awards) 

 

 

 

 

 

 



###    2024 BTCA Award Recipients  expand\_more  

**Treating Fragile X syndrome via cytosine-guanine-guanine repeat contraction**  
[Jeannie Lee](https://www.massgeneral.org/pathology/faculty-and-staff/jeannie-lee-md), MD, PhD (Massachusetts General Hospital)  
   
**Preparation of intravenous oxygen for a first-in-human clinical trial**  
[John Kheir](https://www.childrenshospital.org/directory/john-kheir), MD (Boston Children’s Hospital) and [Yifeng Peng](https://www.childrenshospital.org/research/departments/cardiology-research/basic-translational-cardiovascular-research/translational-research-lab), PhD (Boston Children’s Hospital)  
   
**Brain selective modulation of adrenergic receptors to treat Parkinson’s Disease**  
[Kevin Hodgetts](https://connects.catalyst.harvard.edu/Profiles/display/Person/112665), PhD (Brigham and Women’s Hospital)

 

 [  arrow\_forward  Read about the 2024 BTCA projects ](https://hms.harvard.edu/news/blavatnik-therapeutics-challenge-awards-fuel-translational-research) 

 

 

 

 

 

 



###    2023 BTCA Award Recipients  expand\_more  

**Dual-targeted “OR-logic” gated CAR T cell therapy to achieve cure in multiple myeloma**  
[Eric Smith](https://ericsmithlab.dana-farber.org/), MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute)  
   
**Development of allosteric EGFR inhibitor EAI-432 for non-small cell lung cancer**  
[Michael Eck](https://biophysics.fas.harvard.edu/people/michael-j-eck), MD, PhD (Harvard Medical School/Dana-Farber Cancer Institute) and David Scott (Dana-Farber Cancer Institute)  
   
**Off-the-shelf tissue for cartilage repair**  
[April Craft](https://hscrb.harvard.edu/people/april-craft/), PhD (Harvard University/Boston Children’s Hospital)  
   
**Sidestepping iron restriction to treat anemia**  
[Eric Gale](https://www.martinos.org/investigator/eric-gale/), PhD (Harvard Medical School/Massachusetts General Hospital)  
   
**Enhancing activity of CAR T cells for the treatment of multiple myeloma**  
[Mohammad Rashidian](https://rashidianlab.dana-farber.org/), PhD (Harvard Medical School/Dana-Farber Cancer Institute)

 

 [  arrow\_forward  Read about the 2023 BTCA projects ](https://hms.harvard.edu/news/annual-awards-propel-basic-discoveries-clinic) 

 

 

 

 

 

 



###    2022 BTCA Award Recipients  expand\_more  

**β-Carboline GABAA partial-PAMs for essential tremor and related disorders**  
[Kevin Hodgetts](https://connects.catalyst.harvard.edu/Profiles/display/Person/112665), PhD (Harvard Medical School/Brigham and Women’s Hospital)

**Targeting R-loop and mRNA dependent repair pathway in cancer therapy**  
[Li Lan](https://connects.catalyst.harvard.edu/profiles/display/Person/172776), PhD (Harvard Medical School/Massachusetts General Hospital) and Lee Zou (Harvard Medical School/Massachusetts General Hospital)

**Targeted treatment of pemphigus vulgaris**  
[Mohammad Rashidian](https://rashidianlab.dana-farber.org/), PhD (Harvard Medical School/Dana Farber Cancer Institute), Ramon Almela (Tufts University), and Erin Wei (Nebraska Medical Center)

 

 



###    2021 BTCA Award Recipients  expand\_more  

**Identifying small-molecule therapies for telomere diseases**

[Suneet Agarwal](https://hsci.harvard.edu/people/suneet-agarwal-md-phd), MD, PhD (HMS Associate Professor of Pediatrics at Boston Children’s Hospital)

**Gene therapy for congenital deafness and blindness**

[David Corey](https://connects.catalyst.harvard.edu/Profiles/display/Person/10166), PhD (Bertarelli Professor of Translational Medical Science, Blavatnik Institute at HMS)

**Protein therapy for frozen shoulder**

[Ara Nazarian](https://connects.catalyst.harvard.edu/Profiles/display/Person/30152), Dr. Sc. (HMS Professor of Orthopedic Surgery at Beth Israel Deaconess Medical Center)

**Treating pediatric anemia with gene therapy**

[Vijay Sankaran](https://connects.catalyst.harvard.edu/Profiles/display/Person/63827), MD, PhD (HMS Associate Professor of Pediatrics at Boston Children’s Hospital)

 

 [  arrow\_forward  Read about the 2021 BTCA projects ](https://hms.harvard.edu/news/catalyzing-new-treatments) 

 

 

 

 

 

 



###    2020 BTCA Award Recipients  expand\_more  

**Therapeutic gene editing of ELANE for severe congenital neutropenia**

[Daniel Bauer](https://hsci.harvard.edu/people/daniel-e-bauer-md-phd), MD, PhD (Boston Children’s Hospital)

**Selectin inhibitors for prevention of cancer-associated venous thromboembolism**

[Elliot Chaikof](https://hsci.harvard.edu/people/elliot-chaikof-md-phd), MD, PhD (Beth Israel Deaconess Medical Center)

**A novel therapy to achieve insulin-independent glycemic control in type 1 diabetes**

[Christiane Ferran](https://connects.catalyst.harvard.edu/Profiles/display/Person/83689), MD, PhD (Beth Israel Deaconess Medical Center)

**A first-in-class therapeutic antibody for treatment of asthma**

[Steven Greenberg](https://connects.catalyst.harvard.edu/Profiles/display/Person/39752), MD (Brigham and Women’s Hospital)

**Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases**

[Peter Park](https://dbmi.hms.harvard.edu/people/peter-park), PhD (Harvard Medical School)

 

 [  arrow\_forward  Read about the 2020 BTCA projects ](https://hms.harvard.edu/news/investing-exceptional-promise)